Danaher Corp (DHR) Stock: A Rollercoaster Ride You Might Want to Avoid
Barclays has recently raised Danaher Corp (DHR) stock to Overweight rating, as announced on April 10, 2025, according to Finviz. Earlier, on March 21, 2025, Goldman had raised the stock from a Neutral to Buy, setting a price target of $260. Stifel also raised Buy rating with a price target of $260. Additionally, Raymond James […]
Is FNB Corp (FNB) Stock Ready for Another Surge?
BofA Securities has recently initiated FNB Corp (FNB) stock to Buy rating, as announced on January 11, 2024, according to Finviz. Earlier, on April 4, 2023, Stephens had initiated the stock to Overweight, setting a price target of $15. Keefe Bruyette also reduced Mkt Perform rating with a price target of $15.50. Additionally, Jefferies reduced […]
The Untold Story of eBay Inc (EBAY) Stock’s Growth: Is It Too Risky?
Jefferies has recently reduced eBay Inc (EBAY) stock to Underperform rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 9, 2024, Wedbush had initiated the stock to Neutral, setting a price target of $70. Bernstein also raised Outperform rating with a price target of $70. Additionally, Needham resumed Buy rating on […]
Is Enterprise Products Partners LP (EPD) Stock’s Valuation Too Good to Be True?
Scotiabank has recently initiated Enterprise Products Partners LP (EPD) stock to Sector Perform rating, as announced on January 10, 2025, according to Finviz. Earlier, on January 10, 2025, Wolfe Research had reduced the stock from a Outperform to Peer Perform. Wells Fargo also reduced Equal Weight rating with a price target of $35. Additionally, BofA […]
Why Bristol-Myers Squibb Co (BMY) Stock Could Be a Huge Risk for You
Jefferies has recently raised Bristol-Myers Squibb Co (BMY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Neutral, setting a price target of $63. Wolfe Research also initiated Peer Perform rating. Additionally, Daiwa Securities raised Outperform rating on November […]
Why Albemarle Corp (ALB) Stock Might Be a Big Loss for You
Evercore ISI has recently reduced Albemarle Corp (ALB) stock rating, as announced on February 5, 2025, according to Finviz. Earlier, on January 28, 2025, Truist had initiated the stock to Hold, setting a price target of $96. Clarksons Platou also initiated Buy rating with a price target of $112. Additionally, Robert W. Baird reduced Neutral […]
What’s Really Driving Archer-Daniels-Midland Co (ADM) Stock’s Downward Trend Right Now?
BofA Securities has recently raised Archer-Daniels-Midland Co (ADM) stock to Neutral rating, as announced on April 15, 2025, according to Finviz. Earlier, on January 14, 2025, BofA Securities had reduced the stock from a Neutral to Underperform, setting a price target of $54 for ADM stock. Stephens also resumed rating with a price target of […]
Atlassian Corp (TEAM) Stock: Is It Time for a Major Shift?
Robert W. Baird has recently raised Atlassian Corp (TEAM) stock to Outperform rating, as announced on April 14, 2025, according to Finviz. Earlier, on April 10, 2025, Macquarie had raised the stock from a Neutral to Outperform, setting a price target of $270. BMO Capital Markets also reiterated Outperform rating with a price target of […]
The Future of SM Energy Co (SM) Stock: Will It Underperform?
JP Morgan has recently reduced SM Energy Co (SM) stock to Neutral rating, as announced on December 5, 2024, according to Finviz. Earlier, on October 15, 2024, TD Cowen had raised the stock from a Hold to Buy, setting a price target of $60 for SM stock. Tudor, Pickering, Holt & Co. also raised Buy […]
Is Kura Oncology Inc (KURA) Stock About to Hit a New High?
BTIG Research has recently reduced Kura Oncology Inc (KURA) stock to Neutral rating, as announced on February 6, 2025, according to Finviz. Earlier, on October 24, 2024, UBS had initiated the stock to Buy, setting a price target of $27. Stifel also reduced Hold rating with a price target of $19. Additionally, Mizuho initiated Buy […]
